Group 1 - Modern industrialization is the foundation and core of a modern industrial system, emphasizing the need to strengthen the real economy and promote technological innovation and digital transformation across various regions [1] - The "14th Five-Year Plan" has seen a steady improvement in China's industrial technological innovation capabilities, with significant achievements in original breakthroughs and production line transformations, enhancing the micro-foundation for new industrialization [2] - The development of industrial clusters is crucial for enhancing the resilience and competitiveness of supply chains, with successful examples like the medical device industry park in Xiangtan, Hunan, showcasing the power of cluster development [3] Group 2 - The integration of digital technology with the real economy is a defining feature of new industrialization, driving traditional industries to rejuvenate and emerging industries to accelerate growth [4] - Companies are encouraged to overcome challenges in digital transformation through government support and a shift in mindset towards high-end, green, and intelligent development [4] - The ongoing digital transformation in manufacturing is expanding the scope of smart factories and industrial internet, providing a significant boost to new industrialization [4]

Investment Rating - The report initiates coverage with an OUTPERFORM rating for the company, with a target price of $10.10, compared to the current price of $5.87 [3][4]. Core Insights - The company is positioned in the burgeoning light medical aesthetics industry in China, benefiting from increasing consumer demand for beauty and anti-aging solutions, a diverse range of upstream products, and improving industry standards and transparency [4][5]. - Despite a significant stock price increase of 487% since mid-June, the company is expected to continue its upward trajectory due to rapid expansion and substantial growth potential [4][6]. Company Overview - The company, So-Young (SY US), is a leading medical aesthetics service group in China and the first online medical aesthetics service platform listed on NASDAQ, established in 2013 [10]. - As of January 2024, the platform has onboarded 57,464 certified institutions and 43,771 physicians, with over 630 million beauty diaries and 210 million downloads [10][11]. Market Overview - The light medical aesthetics market in China is projected to grow at a CAGR of 16.3%, reaching RMB 339 billion by 2030, driven by increased consumer awareness and a diverse product supply [5][32]. - The market remains highly fragmented, with a significant opportunity for chain institutions to increase their penetration due to the standardized nature of light medical aesthetics projects [5][41]. Competitive Advantages - The company aims to address industry pain points such as information asymmetry and high customer acquisition costs through its supply chain advantages and digital marketing capabilities [6][47]. - The rapid expansion of the company's clinics, from 1 in May 2023 to 32 by mid-2025, showcases its strong execution capabilities and ambition to reach 1,000 clinics in the next 7-8 years [6][58]. Financial Analysis and Forecast - Revenue is projected to grow from RMB 1.47 billion in 2024 to RMB 2.68 billion in 2026, with a significant increase in net profit expected in 2026 [3][4]. - The company’s traditional POP business is expected to stabilize, contributing positive cash flow, while the medical aesthetics segment is anticipated to become a new growth driver [7][12]. Valuation and Recommendations - The report employs a segmented valuation approach, assigning different P/E ratios to various business segments, resulting in a target price of $10.10 [7][4]. - The company is expected to maintain a competitive edge through its cost-effective operations and strong digital capabilities, with a projected net profit margin improvement to 20% in the future [7][78].